| LTA |
LTA, TNFB, TNFSF1: Lymphotoxin-alpha precursor |
TNF |
TNF, TNFA, TNFSF2: Tumor necrosis factor precursor |
27.950 |
Evidence |
O
|
| CRKL |
CRKL: Crk-like protein |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
27.950 |
Evidence |
O
|
| GDI2 |
GDI2, RABGDIB: Rab GDP dissociation inhibitor beta |
RAB11A |
RAB11A, RAB11: Ras-related protein Rab-11A |
27.930 |
Evidence |
O
|
| U2AF2 |
U2AF2, U2AF65: Splicing factor U2AF 65 kDa subunit |
U2AF1 |
U2AF1, U2AF35, U2AFBP: Splicing factor U2AF 35 kDa subunit |
27.870 |
Evidence |
O
|
| ACTN4 |
ACTN4: Alpha-actinin-4 |
ACTN2 |
ACTN2: Alpha-actinin-2 |
27.870 |
Evidence |
O
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
PARD6G |
PARD6G, PAR6G: Partitioning defective 6 homolog gamma |
27.870 |
Evidence |
O
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
27.800 |
Evidence |
O
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
GRK5 |
GRK5, GPRK5: G protein-coupled receptor kinase 5 |
27.110 |
Evidence |
O
|
| STX12 |
STX12: Syntaxin-12 |
NAPA |
IPI00420053 |
27.060 |
Evidence |
O
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
FOXO1A |
FOXO1A, FKHR: Forkhead box protein O1A |
26.890 |
Evidence |
O
|
| VIL2 |
IPI00479359 |
MSN |
MSN: Moesin |
26.890 |
Evidence |
O
|
| EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
EIF5 |
EIF5: Eukaryotic translation initiation factor 5 |
26.580 |
Evidence |
O
|
| CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
26.470 |
Evidence |
O
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
ORC2L |
ORC2L, ORC2: Origin recognition complex subunit 2 |
26.440 |
Evidence |
O
|
| HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
26.080 |
Evidence |
O
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
HDAC2 |
HDAC2: Histone deacetylase 2 |
26.080 |
Evidence |
O
|
| CSNK1E |
CSNK1E: Casein kinase I isoform epsilon |
NACA |
NACA, HSD48: Nascent polypeptide-associated complex subunit alpha |
26.050 |
Evidence |
O
|
| SMARCA5 |
SMARCA5, SNF2H, WCRF135: SWI/SNF-related matrix-associated actin-dependent regul |
KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
25.700 |
Evidence |
O
|
| EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
EFNA5 |
EFNA5, EPLG7, LERK7: Ephrin-A5 precursor |
25.660 |
Evidence |
O
|
| JUNB |
JUNB: Transcription factor jun-B |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
25.3 |
Evidence |
O
|
| RB1 |
RB1: Retinoblastoma-associated protein |
CDK4 |
CDK4: Cell division protein kinase 4 |
25.060 |
Evidence |
O
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
CCND2 |
CCND2: G1/S-specific cyclin-D2 |
25.030 |
Evidence |
O
|
| TNFRSF10A |
TNFRSF10A, APO2, DR4, TRAILR1: Tumor necrosis factor receptor superfamily member |
FADD |
FADD, MORT1: Protein FADD |
24.100 |
Evidence |
O
|
| CCNA2 |
CCNA2, CCN1, CCNA: Cyclin-A2 |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
23.940 |
Evidence |
O
|
| ACTG1 |
ACTB: Actin, cytoplasmic 1 |
ACTC |
ACTC1, ACTC: Actin, alpha cardiac muscle 1 |
23.480 |
Evidence |
O
|
